[A study of the comparative efficiency of ifenprodil and ritodrine in the treatment of threatened premature labour (author's transl)].
The study compares a sequential test of a beta mimetic drug (ritodrine) and an alpha inhibitor (ifenoprodil) to show that the beta mimetic drug is superior in treating threatened premature labour, because it has a success rate of 90 per cent whereas the second has a success rate of 45 per cent. Ritodrine produces secondary effects in 69 per cent of cases.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D011247:Pregnancy; D011412:Propanolamines / Q000627:therapeutic use*; D012312:Ritodrine / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D010880:Piperidines; D011412:Propanolamines; D012312:Ritodrine
Etude de l'efficacité comparée de l'ifenprodil et de la ritodrine pour le traitement de la menace d'accouchement prématuré.